Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
Article in JTO Clinical and Research Reports (December 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in JTO Clinical and Research Reports (December 2023)
Article in Cancer Cell International (August 2023)
Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (June 2023)